Phio Pharmaceuticals Corp.PHIO
What Phio Pharmaceuticals Corp. does.
Phio Pharmaceuticals Corp. (“ Phio ,” “ we ,” “ our ” or the “ Company ”) is a clinical stage biopharmaceutical company whose proprietary INTASYL® small interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. We are developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body’s ability to fight cancer, without the need for specialized formulations or drug delivery systems. We are committed to discovering and developing innovative cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment and a single reportable segment.
Overall, RNA is involved in the synthesis, regulation and expression of proteins. RNA takes the instructions from DNA and turns those instructions into proteins within the body’s cells. RNA interference, or RNAi, is a biological process that inhibits the expression of genes or the production of proteins. Diseases are often related to the incorrect protein being made, excessive amounts of a specific protein being made, or the correct protein being made, but at the wrong location or time. RNAi offers a novel approach to drug development because RNAi compounds can be designed to silence any one of the thousands of human genes, many of which are considered “undruggable” by traditional therapeutics.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $0 | — | — | — | — | — |
| Net income | -$8.8M | -$13.3M | -$11.5M | -$10.8M | -$7.2M | -$8.7M |
| Free cash flow | -$8.8M | -$11.9M | -$12.3M | -$10.8M | -$7.1M | -$8.0M |
More on PHIO.
- Phio Pharmaceuticals Corp. summary
- Phio Pharmaceuticals Corp. financial statements
- Phio Pharmaceuticals Corp. key metrics
- Phio Pharmaceuticals Corp. health scores and style box
- Phio Pharmaceuticals Corp. earnings
- Phio Pharmaceuticals Corp. dividends
- Phio Pharmaceuticals Corp. valuation
- Phio Pharmaceuticals Corp. ownership and insiders
- Phio Pharmaceuticals Corp. peers
Figures from Phio Pharmaceuticals Corp.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.